Branger Annette B, Eckmann David M
Department of Anesthesia and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Anesthesiology. 2002 Apr;96(4):971-9. doi: 10.1097/00000542-200204000-00027.
Cerebrovascular gas embolism can cause profound neurologic dysfunction, and there are few treatments. The authors tested the hypothesis that an exogenous surfactant can be delivered into the bloodstream to alter the air-blood interfacial mechanics of an intravascular gas embolism and produce bubble conformations, which favor more rapid bubble absorption.
Microbubbles of air were injected into the rat cremaster microcirculation after intravascular administration of either saline (control, n = 5) or Dow Corning Antifoam 1510US (surfactant, n = 5). Embolism dimensions and dynamics were directly observed after entrapment using intravital microscopy.
To achieve embolization, the surfactant group required twice as many injections as did controls (3.2 +/- 1.3 vs. 1.6 +/- 0.9; P < 0.05). There was no difference in the initial lodging configuration between groups. After bubble entrapment, there was significantly more local vasoconstriction in the surfactant group (24.2% average decrease in diameter) than in controls (3.4%; P < 0.05). This was accompanied by a 92.7% bubble elongation in the surfactant group versus 8.2% in controls (P < 0.05). Embolism shape change was coupled with surfactant-enhanced breakup into multiple smaller bubbles, which reabsorbed nearly 30% more rapidly than did parent bubbles in the control group (P < 0.05).
Intravascular exogenous surfactant did not affect initial bubble conformation but dramatically increased bubble breakup and rate of reabsorption. This was evidenced by both the large shape change after entrapment and enhancement of bubble breakup in the surfactant group. These dynamic surfactant-induced changes increase the total embolism surface area and markedly accelerate bubble reabsorption.
脑血管气体栓塞可导致严重的神经功能障碍,且治疗方法有限。作者测试了这样一个假设,即外源性表面活性剂可注入血流,以改变血管内气体栓塞的气血界面力学,并产生有利于更快气泡吸收的气泡形态。
在血管内注射生理盐水(对照组,n = 5)或道康宁抗泡剂1510US(表面活性剂,n = 5)后,将空气微泡注入大鼠提睾肌微循环。使用活体显微镜直接观察栓塞形成后的尺寸和动态变化。
为实现栓塞,表面活性剂组所需的注射次数是对照组的两倍(3.2±1.3次对1.6±0.9次;P<0.05)。两组之间初始滞留形态无差异。气泡滞留后,表面活性剂组的局部血管收缩明显更显著(直径平均降低24.2%),而对照组为3.4%(P<0.05)。这伴随着表面活性剂组气泡伸长92.7%,而对照组为8.2%(P<0.05)。栓塞形状的改变伴随着表面活性剂增强的气泡破裂成多个较小的气泡,其再吸收速度比对照组的母气泡快近30%(P<0.05)。
血管内外源性表面活性剂不影响初始气泡形态,但显著增加气泡破裂和再吸收速度。这在表面活性剂组中气泡滞留后的巨大形状变化和气泡破裂增强中得到了证明。这些由表面活性剂引起的动态变化增加了栓塞的总表面积,并显著加速了气泡的再吸收。